The new crisis raises awareness and warns of an increase in Corona injuries.
A new crisis looms on the horizon, represented by the unavailability of the required number of coronavirus screening tests, which threatens to increase Corona infections, especially with the onset of winter.
Swiss pharmaceutical company Roche announced that the tens of millions of COVID-19 detection tests produced by the company would not be enough this winter.
This is at a time when the rate of infection with the emerging coronavirus, which causes disease (Covid-19), is increasing in the northern hemisphere.
On Saturday, Bloomberg News, citing CEO Roch Severin Schwan, said that the Swiss giant was in the process of producing more than 80 million rapid tests for Corona per month by the end of this year, in addition to slower polymerase chain reaction (PCR) tests. but high resolution. Has been shipped worldwide since last January.
But even this will be less than demand amid persistent supply problems, so officials must continue to prioritize resources.
“We could sell more if we only had supplies,” Chuan said in an interview with Bloomberg. “The supply chain is complex, and things have to flow together.”